Basel, Switzerland

Peter Smith-Jones

This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Smith-Jones. Retrieved from https://idiyas.com/inventor/peter-smith-jones-8c8huayt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Peter Smith-Jones

Introduction

Peter Smith-Jones is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide compounds. With a total of 2 patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Among his latest patents is a groundbreaking invention related to peptides. The patent titled "Chelated peptides, complexes thereof, pharmaceutical compositions containing them and their use as radiopharmaceuticals" showcases his innovative approach to enhancing the efficacy of pharmaceutical compounds.

Career Highlights

Peter Smith-Jones is currently employed at Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.

Collaborations

Throughout his career, Peter has collaborated with esteemed colleagues, including Rainer Albert and Christian Bruns. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Peter Smith-Jones exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…